The metopirone test of pituitary corticotrophin release. Evaluation of 101 tests.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000503:physiopathology; D002648:Child; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006964:Hyperpituitarism / Q000175:diagnosis*; D007018:Hypopituitarism / Q000175:diagnosis*; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D014149:Tranquilizing Agents / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D005938:Glucocorticoids; D014149:Tranquilizing Agents; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone